Skip to Main Content

Paper Details

Radiation Therapy for IDH-Mutant Grade 2 and Grade 3 Diffuse Glioma: An ASTRO Clinical Practice Guideline.
Pract Radiat Oncol
12
2022
1p/19q codeleted, IDH, IDH-Mutant, IDH-mutant, Tumours, astrocytoma, diffuse glioma, grade 3, high, isocitrate, isocitrate dehydrogenase (IDH), oligodendroglioma, patients
Author NameAffiliation
Daniel J BratNorthwestern University Feinberg School of Medicine
John P KirkpatrickDuke University
Joshua D PalmerArthur G. James Cancer Hospital and Richard J. Solove Research Institute, Ohio State University Comprehensive Cancer Center
Daniel R WahlUniversity of Michigan Medical Center ann arbor
Helen A ShihMassachusetts General Hospital
  • 1 - 5

Datasets

Release 1.2